Pseudo Continent Perineal Colostomy vs Permanent Left Iliac Colostomy After Abdominoperineal Resection for Ultra Low Rectal Adenocarcinoma

NCT04141566 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2020-09-01

No results posted yet for this study

Summary

Aim of this study is to compare the cost-effectiveness and the quality of life in the 6 months following the surgery of a pseudo continent perineal colostomy (PCPC) and a permanent left iliac colostomy (PLIC) following an abdominoperineal resection (APR) for ultra low rectal cancer

Conditions

  • Rectal Neoplasms
  • Colostomy Stoma
  • Quality of Life

Interventions

PROCEDURE

Perineal pseudocontinent colostomy

The procedure is performed in 2stages: as a usual APR starting by a laparoscopic approach esnsuring a complete mesorectal excision,then a perineal approach ensuring an extended excision of the entire internal and external sphincter complex, allowing the excision of the specimen. 8to10cm of tof the colon is resected and harvested as a free graft, stripped of its meso and epiploics , then from its mucosa and placed in an antibiotic solution for 10min. This graft is wrapped snugly around the end of the colon 2-3 cm from its distal end for 1 and a half round. Absorbable 3.0 Sutures are taken to hold it in place. The end of the colon is brought out as a stoma in the perineum. Colonic irrigations are started from the third day according to the protocol previously reported. Patients and one of their family members are daily educated and assisted while performing colonic irrigations by specialized nurses.

PROCEDURE

Permanent left iliac colostomy

After a usual laparoscopic APR, the perineal wound is closed and a permanent left iliac colostomy is performed

Sponsors & Collaborators

  • Institut National d'Oncologie Sidi Mohammed Ben Abdellah

    collaborator UNKNOWN
  • Moroccan Society of Surgery

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Morocco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04141566 on ClinicalTrials.gov